Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,808,443Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1ACCORD BIOPHARMA INC.

02 2AMGEN INC

03 1CELLTRION INC

04 1GENENTECH

05 2GENENTECH INC

06 1MYLAN GMBH

07 1PFIZER INC

08 2SAMSUNG BIOEPIS CO LTD

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

APS Symposium
Not Confirmed
arrow
arrow
APS Symposium
Not Confirmed

TRASTUZUMAB-ANNS

Brand Name : KANJINTI

Dosage Form : VIAL; MULTIDOSE

Dosage Strength : 420MG

Approval Date :

Application Number : 761073

RX/OTC/DISCN :

RLD :

TE Code :

blank

02

APS Symposium
Not Confirmed
arrow
arrow
APS Symposium
Not Confirmed

TRASTUZUMAB-ANNS

Brand Name : KANJINTI

Dosage Form : VIAL;SINGLE-DOSE

Dosage Strength : 150MG

Approval Date :

Application Number : 761073

RX/OTC/DISCN :

RLD :

TE Code :

blank

03

APS Symposium
Not Confirmed
arrow
arrow
APS Symposium
Not Confirmed

TRASTUZUMAB-PKRB

Brand Name : HERZUMA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 420MG

Approval Date :

Application Number : 761091

RX/OTC/DISCN :

RLD :

TE Code :

blank

04

APS Symposium
Not Confirmed
arrow
arrow
APS Symposium
Not Confirmed

TRASTUZUMAB

Brand Name : HERCEPTIN

Dosage Form : VIAL; INTRAVENOUS

Dosage Strength : 21MG/ML

Approval Date :

Application Number : 103792

RX/OTC/DISCN :

RLD :

TE Code :

blank

05

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF

Brand Name : PHESGO

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 1,200MG;600MG;30,000UNITS

Approval Date :

Application Number : 761170

RX/OTC/DISCN :

RLD :

TE Code :

blank

06

APS Symposium
Not Confirmed
arrow
arrow
APS Symposium
Not Confirmed

PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF

Brand Name : PHESGO

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 600MG;600MG;20,000UNITS

Approval Date :

Application Number : 761170

RX/OTC/DISCN :

RLD :

TE Code :

blank

07

APS Symposium
Not Confirmed
arrow

08

APS Symposium
Not Confirmed
arrow
arrow
APS Symposium
Not Confirmed

TRASTUZUMAB-DTTB

Brand Name : ONTRUZANT

Dosage Form : POWDER;IV (INFUSION)

Dosage Strength : 150MG

Approval Date :

Application Number : 761100

RX/OTC/DISCN :

RLD :

TE Code :

blank

09

APS Symposium
Not Confirmed
arrow
arrow
APS Symposium
Not Confirmed

TRASTUZUMAB-DTTB

Brand Name : ONTRUZANT

Dosage Form : POWDER;IV (INFUSION)

Dosage Strength : 420MG

Approval Date :

Application Number : 761100

RX/OTC/DISCN :

RLD :

TE Code :

blank

10

APS Symposium
Not Confirmed
arrow
arrow
APS Symposium
Not Confirmed

TRASTUZUMAB-DKST

Brand Name : OGIVRI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 420MG/VIAL

Approval Date :

Application Number : 761074

RX/OTC/DISCN :

RLD :

TE Code :

blank